356 related articles for article (PubMed ID: 29516409)
21. The role of the multidisciplinary team in the management of psoriatic arthritis.
Jadon DR; Helliwell PS
Musculoskeletal Care; 2022 Nov; 20 Suppl 1(Suppl 1):S32-S40. PubMed ID: 36356109
[TBL] [Abstract][Full Text] [Related]
22. Multidisciplinary dermatology-rheumatology management for patients with moderate-to-severe psoriasis and psoriatic arthritis: a systematic review.
Cobo-Ibáñez T; Villaverde V; Seoane-Mato D; Muñoz-Fernández S; Guerra M; Del Campo PD; Cañete JD
Rheumatol Int; 2016 Feb; 36(2):221-9. PubMed ID: 26438388
[TBL] [Abstract][Full Text] [Related]
23. Immune-mediated inflammatory diseases and other comorbidities in patients with psoriasis: baseline characteristics of patients in the AQUILES study.
Vanaclocha F; Crespo-Erchiga V; Jiménez-Puya R; Puig L; Sánchez-Carazo JL; Ferrán M; Sancho C; Juliá B; Cea-Calvo L; Marín-Jiménez I; García-Vicuña R;
Actas Dermosifiliogr; 2015; 106(1):35-43. PubMed ID: 25091923
[TBL] [Abstract][Full Text] [Related]
24. Sympathetic Nerve Hyperactivity in the Spleen: Causal for Nonpathogenic-Driven Chronic Immune-Mediated Inflammatory Diseases (IMIDs)?
Bellinger DL; Lorton D
Int J Mol Sci; 2018 Apr; 19(4):. PubMed ID: 29652832
[TBL] [Abstract][Full Text] [Related]
25. Comorbidities in patients with spondyloarthritis.
van der Horst-Bruinsma IE; Nurmohamed MT; Landewé RB
Rheum Dis Clin North Am; 2012 Aug; 38(3):523-38. PubMed ID: 23083753
[TBL] [Abstract][Full Text] [Related]
26. Adalimumab in the treatment of immune-mediated diseases.
Lapadula G; Marchesoni A; Armuzzi A; Blandizzi C; Caporali R; Chimenti S; Cimaz R; Cimino L; Gionchetti P; Girolomoni G; Lionetti P; Marcellusi A; Mennini FS; Salvarani C
Int J Immunopathol Pharmacol; 2014; 27(1 Suppl):33-48. PubMed ID: 24774505
[TBL] [Abstract][Full Text] [Related]
27. Comprehensive reproductive healthcare for women with immune-mediated inflammatory diseases: Addressing rheumatoid arthritis, spondyloarthritis and inflammatory bowel disease through life's stages.
Andreoli L; Guadagni I; Picarelli G; Principi M
Autoimmun Rev; 2024 Mar; 23(3):103507. PubMed ID: 38142899
[TBL] [Abstract][Full Text] [Related]
28. Patients with inflammatory bowel disease have increased risk of autoimmune and inflammatory diseases.
Halling ML; Kjeldsen J; Knudsen T; Nielsen J; Hansen LK
World J Gastroenterol; 2017 Sep; 23(33):6137-6146. PubMed ID: 28970729
[TBL] [Abstract][Full Text] [Related]
29. Acute anterior uveitis and other extra-articular manifestations of spondyloarthritis.
Mitulescu TC; Popescu C; Naie A; Predeţeanu D; Popescu V; Alexandrescu C; Voinea LM
J Med Life; 2015; 8(3):319-25. PubMed ID: 26351533
[TBL] [Abstract][Full Text] [Related]
30. Italian Expert Panel on the management of patients with coexisting spondyloarthritis and inflammatory bowel disease.
Olivieri I; Cantini F; Castiglione F; Felice C; Gionchetti P; Orlando A; Salvarani C; Scarpa R; Vecchi M; Armuzzi A
Autoimmun Rev; 2014 Aug; 13(8):822-30. PubMed ID: 24726868
[TBL] [Abstract][Full Text] [Related]
31. A step-wise approach for establishing a multidisciplinary team for the management of tuberous sclerosis complex: a Delphi consensus report.
Auvin S; Bissler JJ; Cottin V; Fujimoto A; Hofbauer GFL; Jansen AC; Jóźwiak S; Kerecuk L; Kingswood JC; Moavero R; Torra R; Villanueva V
Orphanet J Rare Dis; 2019 Apr; 14(1):91. PubMed ID: 31039793
[TBL] [Abstract][Full Text] [Related]
32. Adalimumab efficacy in enteropathic spondyloarthritis: A 12-mo observational multidisciplinary study.
Luchetti MM; Benfaremo D; Ciccia F; Bolognini L; Ciferri M; Farinelli A; Rossini M; Mosca P; Triolo G; Gabrielli A
World J Gastroenterol; 2017 Oct; 23(39):7139-7149. PubMed ID: 29093622
[TBL] [Abstract][Full Text] [Related]
33. Enteropathic spondyloarthritis: Results from a large nationwide database analysis.
Picchianti-Diamanti A; Lorenzetti R; Chimenti MS; Luchetti MM; Conigliaro P; Canofari C; Benfaremo D; Bruzzese V; Laganà B; Perricone R;
Autoimmun Rev; 2020 Feb; 19(2):102457. PubMed ID: 31838160
[TBL] [Abstract][Full Text] [Related]
34. Review article: acute severe ulcerative colitis - evidence-based consensus statements.
Chen JH; Andrews JM; Kariyawasam V; Moran N; Gounder P; Collins G; Walsh AJ; Connor S; Lee TW; Koh CE; Chang J; Paramsothy S; Tattersall S; Lemberg DA; Radford-Smith G; Lawrance IC; McLachlan A; Moore GT; Corte C; Katelaris P; Leong RW;
Aliment Pharmacol Ther; 2016 Jul; 44(2):127-44. PubMed ID: 27226344
[TBL] [Abstract][Full Text] [Related]
35. Immune-mediated inflammatory diseases: Common and different pathogenic and clinical features.
Monteleone G; Moscardelli A; Colella A; Marafini I; Salvatori S
Autoimmun Rev; 2023 Oct; 22(10):103410. PubMed ID: 37597601
[TBL] [Abstract][Full Text] [Related]
36. Two-year incidence of psoriasis, uveitis and inflammatory bowel disease in patients with spondyloarthritis: A study in the AQUILES cohort.
García-Vicuña R; Zarco P; González CM; Vanaclocha F; Marín-Jiménez I; Cea-Calvo L
Reumatol Clin; 2016; 12(1):22-6. PubMed ID: 25683367
[TBL] [Abstract][Full Text] [Related]
37. Impact of red and processed meat and fibre intake on treatment outcomes among patients with chronic inflammatory diseases: protocol for a prospective cohort study of prognostic factors and personalised medicine.
Christensen R; Heitmann BL; Andersen KW; Nielsen OH; Sørensen SB; Jawhara M; Bygum A; Hvid L; Grauslund J; Wied J; Glerup H; Fredberg U; Villadsen JA; Kjær SG; Fallingborg J; Moghadd SAGR; Knudsen T; Brodersen J; Frøjk J; Dahlerup JF; Bojesen AB; Sorensen GL; Thiel S; Færgeman NJ; Brandslund I; Bennike TB; Stensballe A; Schmidt EB; Franke A; Ellinghaus D; Rosenstiel P; Raes J; Boye M; Werner L; Nielsen CL; Munk HL; Nexøe AB; Ellingsen T; Holmskov U; Kjeldsen J; Andersen V
BMJ Open; 2018 Feb; 8(2):e018166. PubMed ID: 29439003
[TBL] [Abstract][Full Text] [Related]
38. Health-related quality of life in patients with immune mediated inflammatory diseases: A cross-sectional, multidisciplinary study.
Spierings J; Sloeserwij A; Vianen ME; de Boer JH; Sigurdsson V; van de Wijgert JHHM; van Laar JM
Clin Immunol; 2020 May; 214():108392. PubMed ID: 32224157
[TBL] [Abstract][Full Text] [Related]
39. Efficacy and safety of gut microbiota-based therapies in autoimmune and rheumatic diseases: a systematic review and meta-analysis of 80 randomized controlled trials.
Zeng L; Yang K; He Q; Zhu X; Long Z; Wu Y; Chen J; Li Y; Zeng J; Cui G; Xiang W; Hao W; Sun L
BMC Med; 2024 Mar; 22(1):110. PubMed ID: 38475833
[TBL] [Abstract][Full Text] [Related]
40. The role of tumour necrosis factor in the pathogenesis of immune-mediated diseases.
Blandizzi C; Gionchetti P; Armuzzi A; Caporali R; Chimenti S; Cimaz R; Cimino L; Lapadula G; Lionetti P; Marchesoni A; Marcellusi A; Mennini FS; Salvarani C; Girolomoni G
Int J Immunopathol Pharmacol; 2014; 27(1 Suppl):1-10. PubMed ID: 24774503
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
